Literature DB >> 12203776

Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.

Aikaterini Barbouti1, Bertil Johansson, Mattias Höglund, Nils Mauritzson, Bodil Strömbeck, Per-Gunnar Nilsson, Hans J Tanke, Anne Hagemeijer, Felix Mitelman, Thoas Fioretos.   

Abstract

During the initial indolent chronic phase of chronic myeloid leukemia (CML), the t(9;22)(q34;q11), resulting in the Philadelphia chromosome (Ph), is usually the sole cytogenetic anomaly, but as the disease progresses into the accelerated phase (AP), and eventually into aggressive blast crisis (BC), secondary aberrations, mainly unbalanced changes such as +8, i(17q), and +Ph, are frequent. To date, molecular genetic studies of CML BC have mainly focused on alterations of well-known tumor-suppressor genes (e.g., TP53, CDKN2A, and RB1) and oncogenes (e.g., RAS and MYC), whereas limited knowledge is available about the molecular genetic correlates of the unbalanced chromosomal abnormalities. Balanced secondary changes are rare in CML AP/BC, but it is not known whether cryptic chromosomal translocations, generating fusion genes, may be responsible for disease progression in a subgroup of CML. To address this issue, we used multicolor combined binary ratio fluorescence in situ hybridization (FISH), which allows the simultaneous visualization of all 24 chromosomes in different colors, verified by locus-specific FISH in a series of 33 CML cases. Two cryptic balanced translocations, t(7;17)(q32-34;q23) and t(7;17)(p15;q23), were found in two of the five cases showing the t(9;22) as the only cytogenetic change. Using several BAC clones, the breakpoints at 17q23 in both cases were mapped within a 350-kb region. In the case with the 7p15 breakpoint, a BAC clone containing the HOXA gene cluster displayed a split signal, suggesting a possible creation of a fusion gene involving a member of the HOXA family. Furthermore, one case with a partially cryptic t(9;11)(p21-22;q23) and an MLL rearrangement as well as a previously unreported t(3;10)(p22;p12-13) were identified. Altogether, a refined karyotypic description was achieved in 12 (36%) of the 33 investigated cases, illustrating the value of using multicolor FISH for identifying pathogenetically important aberrations in CML AP/BC. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12203776     DOI: 10.1002/gcc.10099

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  A rare case of three-way complex variant translocation in chronic myeloid leukemia t(6;9;22)(p21;q34;q11): A case report.

Authors:  Muhammad Asif; Abrar Hussain; Abdul Wali; Nazeer Ahmad; Naheed Sajjad; Muhammad Amir; Irfan Ali; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Biomed Rep       Date:  2017-08-17

2.  The Human MSI2 Gene is Associated with Schizophrenia in the Chinese Han Population.

Authors:  Zhilin Luan; Tianlan Lu; Yanyan Ruan; Weihua Yue; Dai Zhang
Journal:  Neurosci Bull       Date:  2016-04-08       Impact factor: 5.203

3.  Atypical chronic myeloid leukemia with isochromosome (X)(p10): A case report.

Authors:  Masahide Yamamoto; Sayaka Suzuki; Jun-Ichi Mukae; Keisuke Tanaka; Ken Watanabe; Gaku Oshikawa; Tetsuya Fukuda; Naomi Murakami; Osamu Miura
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

4.  The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats.

Authors:  Aikaterini Barbouti; Pawel Stankiewicz; Chad Nusbaum; Christina Cuomo; April Cook; Mattias Höglund; Bertil Johansson; Anne Hagemeijer; Sung-Sup Park; Felix Mitelman; James R Lupski; Thoas Fioretos
Journal:  Am J Hum Genet       Date:  2003-12-08       Impact factor: 11.025

Review 5.  Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

Authors:  Christian Sillaber; Matthias Mayerhofer; Hermine Agis; Verena Sagaster; Christine Mannhalter; Wolfgang R Sperr; Klaus Geissler; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

6.  Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib.

Authors:  Adriana Zámečníkova
Journal:  Hematol Rep       Date:  2011-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.